These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302 [TBL] [Abstract][Full Text] [Related]
9. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair. Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275 [TBL] [Abstract][Full Text] [Related]
10. PARP-1 inhibition induces a late increase in the level of reactive oxygen species in cells after ionizing radiation. Cieślar-Pobuda A; Saenko Y; Rzeszowska-Wolny J Mutat Res; 2012 Apr; 732(1-2):9-15. PubMed ID: 22321899 [TBL] [Abstract][Full Text] [Related]
11. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653 [TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Singer E; Judkins J; Salomonis N; Matlaf L; Soteropoulos P; McAllister S; Soroceanu L Cell Death Dis; 2015 Jan; 6(1):e1601. PubMed ID: 25590811 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415 [TBL] [Abstract][Full Text] [Related]
14. Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells. Carruthers RD; Ahmed SU; Ramachandran S; Strathdee K; Kurian KM; Hedley A; Gomez-Roman N; Kalna G; Neilson M; Gilmour L; Stevenson KH; Hammond EM; Chalmers AJ Cancer Res; 2018 Sep; 78(17):5060-5071. PubMed ID: 29976574 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials. Wang L; Yang C; Xie C; Jiang J; Gao M; Fu L; Li Y; Bao X; Fu H; Lou L Cancer Sci; 2019 Mar; 110(3):1064-1075. PubMed ID: 30663191 [TBL] [Abstract][Full Text] [Related]
16. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671 [TBL] [Abstract][Full Text] [Related]
17. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines. Lin PH; Lin CH; Huang CC; Chuang MC; Lin P Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation. Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155 [TBL] [Abstract][Full Text] [Related]
19. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells. Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865 [TBL] [Abstract][Full Text] [Related]